Skip to main content

‘Significant progress’ for life sciences business Optibiotix

‘Significant progress’ for life sciences business Optibiotix

Optibiotix says it has made “significant progress” developing a pipeline of innovative products in the first half of the year as it evolves from a technology company to a product firm, following the flotation of its skincare-focused subsidiary and investment in a weight loss business.

Stephen O’Hara, CEO of OptiBiotix, said: “OptiBiotix has made significant progress in the last six months developing a pipeline of innovative products with a strong scientific and clinical evidence base.”

See the article in full at TheBusinessDesk.com